期刊文献+

N‑乙酰半胱氨酸在难治性勃起功能障碍中的应用

Application of N-acetylcysteine in refractory erectile dysfunction
下载PDF
导出
摘要 勃起功能障碍(ED)是男科门诊中常见的疾病。虽然5-型磷酸二酯酶抑制剂已经可以使70%的ED患者勃起功能得到显著改善,但其对难治性ED(包括老年性ED、糖尿病性ED以及阴茎海绵体神经损伤性ED)疗效欠佳或无效。因此,寻找理想的难治性ED干预方式,成为了男科学领域的难点。既往研究表明,N-乙酰半胱氨酸(NAC)不仅在溶解呼吸道黏液和对乙酰基氨基酚过量所致肝毒性解救方面作用明显,在心血管疾病、肿瘤、泌尿男科疾病方面也具有多种功效。本文围绕NAC的抗氧化、抗炎以及其对一氧化氮的调控和抗纤维化作用在难治性ED中可能产生的效应作一综述,以此展望NAC在难治性ED干预中的应用前景。 Erectile dysfunction(ED)is a common disease in andrology clinics.Although oral type 5 phosphodiesterase inhibitors have significantly improved erectile function in 70%of ED patients,the therapeutic effect of them in refractory ED(including aging-related ED,diabetes mellitus-related ED,and ED induced by corpus cavernous nerve injury)is not good or even they have no effects at all.Therefore,exploring an ideal intervention scheme for refractory ED has become a difficult problem in the field of andrology.Previous studies have shown that N-acetylcysteine(NAC)not only plays a significant role in respiratory mucolysis and detoxification of liver toxicity caused by acetylaminophenol overdose,but also has a variety of effects on cardiovascular diseases,tumors,and urological and andrological diseases.This article reviewed the antioxidant and anti-inflammatory effects,as well as its regulation of nitric oxide and anti-fibrosis effects of NAC in refractory ED,in order to evaluate the application prospect of NAC in the treatment of refractory ED.
作者 吴昌静 付福栋 袁久洪 Wu Changjing;Fu Fudong;Yuan Jiuhong(Andrology Laboratory,West China Hospital,Chengdu 610041,China;Institutes for Systems Genetics,West China Hospital,Chengdu 610041,China;Department of Urology,West China Hospital,Chengdu 610041,China)
出处 《实用药物与临床》 CAS 2024年第11期865-869,共5页 Practical Pharmacy and Clinical Remedies
基金 国家自然科学基金(82071639)。
关键词 N-乙酰半胱氨酸 难治性勃起功能障碍 5-型磷酸二酯酶抑制剂 氧化应激 N-acetylcysteine Refractory erectile dysfunction Type 5 phosphodiesterase inhibitor Oxidative stress
  • 相关文献

参考文献2

二级参考文献32

  • 1Lue TF. Erectile dysfunction[J].New England Journal of Medicine,2000,(24):1802-1813.
  • 2Gresser U,Gleiter CH. Erectile dysfunction:Comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil,vardenafil and tadalafil - review of the literature[J].European Journal of medical Research,2002,(10):435-446.
  • 3Nehra A. Oral and non-oral combination therapy for erectile dysfunction[J].Reviews In Urology,2007,(03):99-105.
  • 4Liaw RL,Srilatha B,Adaikan PG. Effects of hydrogen sulfide on erectile function and its possible mechanism(s) of action[J].JOURNAL OF SEXUAL MEDICINE,2011,(07):1853-1864.
  • 5Abdel Aziz MT,Mostafa T,Atta H. Putative role of carbon monoxide signaling pathway in penile erectile function[J].JOURNAL OF SEXUAL MEDICINE,2009,(01):49-60.
  • 6Hatzimouratidis K,Burnett AL,Hatzichristou D. Phosphodiesterase type 5 inhibitors in oostprostatectomy erectile dysfunction:A critical analysis of the basic science rationale and clinical application[J].European Urology,2009,(02):334-347.
  • 7Srilatha B,Muthulakshmi P,Adaikan PG. Endogenous hydrogen sulfide insufficiency as a predictor of sexual dysfunction in aging rats[J].Aging Male,2012,(03):153-158.
  • 8Zuo Z,Jiang J,Jiang R. Effect of periodontitis on erectile function and its possible mechanism[J].JOURNAL OF SEXUAL MEDICINE,2011,(09):2598-2605.
  • 9Sommer F,Engelmann U. Future options for combination therapy in the management of erectile dysfunction in older men[J].Drugs and Aging,2004,(09):555-564.
  • 10Fonseca V,Seftel A,Denne J. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment:Analysis of data from tadalafil clinical trials[J].Diabetologia,2004,(11):1914-1923.doi:10.1007/s00125-004-1549-6.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部